This phase 2 trial tests the safety and effectiveness of combining sacituzumab govitecan (Trodelvy) with trastuzumab (Herceptin) in 28 people with HER2+ metastatic breast cancer that has worsened after treatment with trastuzumab deruxtecan. The goal is to see how many participant…
Phase: PHASE2 • Sponsor: Adrienne G. Waks • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC